Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good in- depth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by dividing the oncology literature into specific subdivisions such as lung cancer, geni- tourinary cancer, pediatric oncology, etc.
Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more.
1. The Lukes-Butler classification of Hodgkin's disease revisited.- 2. Pitfalls in the diagnosis and classification of Hodgkin's disease: Surgical pathology and classification for the 1980's - Is the Lukes-Butler classification still relevant?.- 3. The Reed-Sternberg cell: Biological and clinical significance.- 4. Upon the enigma of Hodgkin's disease and the Reed-Sternberg cell.- 5. Selection of an imaging modality for staging abdominal involvement in the malignant lymphomas - Lymphography or computed tomography?.- 6. The definitive management of limited and intermediate stages of Hodgkin's disease with radiation therapy alone.- 7. The role of combination chemotherapy alone or as an adjuvant to radiation therapy in limited stages of Hodgkin's disease.- 8. Chemotherapy for stage IIIA Hodgkin's disease: The proper role.- 9. The Rappaport classification of the non-Hodgkin's lymphomas: Is it pertinent for the 1980's?.- 10. Nodular mixed cell lymphoma: Is there a potential for a prolonged disease free survival and cure?.- 11. Nodular mixed lymphoma: Failure to demonstrate prolonged disease free survival and cure.- 12. The role of treatment deferral in the management of patients with advanced, indolent non-Hodgkin's lymphomas.- 13. Early intervention with combined modality therapy for 'favorable' non-Hodgkin's lymphomas of advanced stage.